“`
Skyrizi can calm an overactive immune response, but medication management rarely happens in a quiet little bubble. You may also take pain relievers, antibiotics, steroids, vitamins, or another treatment for psoriasis, psoriatic arthritis, Crohn’s disease, or ulcerative colitis. Then come the everyday questions: Can you receive a flu shot? Does grapefruit matter? What happens if you develop an infection? And is alcohol a problem?
The reassuring news is that Skyrizi is not known for a long list of traditional drug interactions. It is a biologic medication rather than a pill processed through the liver in the usual way. Still, “few known interactions” does not translate to “mix it with anything and hope for the best.” Vaccines, immune-suppressing treatments, active infections, liver concerns, and certain companion medications deserve special attention.
What is Skyrizi, and why is its interaction profile different?
Skyrizi is the brand name for risankizumab-rzaa, a monoclonal antibody that blocks interleukin-23, commonly shortened to IL-23. This immune-system protein helps drive inflammation in several chronic conditions. Skyrizi is prescribed for adults with certain forms of plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Many conventional drugs are broken down by cytochrome P450 enzymes in the liver. When two medications compete for or alter those enzymes, blood levels can rise or fall. That is the classic recipe for a drug interaction.
Skyrizi behaves differently. As a monoclonal antibody, it is expected to be broken into small peptides and amino acids through normal protein-processing pathways. In clinical interaction testing, risankizumab did not cause clinically meaningful changes in exposure to several drugs used as markers for major liver-enzyme pathways, including caffeine, warfarin, omeprazole, metoprolol, and midazolam.
That helps explain why Skyrizi has fewer metabolic interactions than many oral medications. It does not eliminate concerns involving immune suppression, infections, vaccines, or the side effects of drugs taken alongside it.
Does Skyrizi interact with other medications?
Other biologics and targeted immune treatments
Combining Skyrizi with another biologic, a Janus kinase inhibitor, or another powerful immune-suppressing treatment is not routine. Two medications that suppress different parts of the immune system may produce additive effects, including a greater risk of infection.
This does not mean every combination is formally prohibited. It means the decision requires a specialist who understands your diagnosis, previous treatments, infection history, and laboratory results. Never use leftover doses of a former biologic while beginning Skyrizi. Biologic overlap is not a do-it-yourself project.
Methotrexate and other non-biologic DMARDs
Skyrizi may be prescribed alone or with certain non-biologic disease-modifying antirheumatic drugs, often called DMARDs. Clinical studies in psoriatic arthritis included many participants who also received methotrexate or another non-biologic DMARD.
No major direct interaction between Skyrizi and methotrexate is identified in the prescribing information. However, methotrexate has its own safety issues, including possible liver, blood-cell, and infection-related effects. Patients taking both treatments may need laboratory monitoring based on their individual health and methotrexate dose.
Alcohol becomes especially important when methotrexate enters the picture. Even though Skyrizi itself is not known to interact directly with alcohol, drinking may increase liver concerns associated with methotrexate. Your full treatment plan matters more than any one drug viewed in isolation.
Corticosteroids
Some people begin Skyrizi while also taking prednisone, budesonide, or another corticosteroid, particularly during treatment for inflammatory bowel disease. These combinations have been used in clinical care and research, but steroids also suppress immune function.
The combined treatment may increase susceptibility to infection, especially with higher steroid doses or prolonged use. Your clinician may gradually reduce the steroid after Skyrizi begins controlling inflammation. Do not stop a long-term corticosteroid suddenly unless your prescriber gives you a tapering plan.
Antibiotics and antifungal medications
Skyrizi is not known to have a direct metabolic interaction with most antibiotics or antifungal drugs. The bigger concern is why you need the antimicrobial treatment.
A clinically important infection may require postponing a Skyrizi dose until the infection has resolved or has been adequately treated. The FDA labeling advises against administering Skyrizi during a clinically important active infection. Contact your care team if you develop fever, chills, persistent cough, shortness of breath, painful skin, unusual sores, urinary symptoms, or worsening diarrhea.
Do not automatically skip an injection because you started an antibiotic, and do not automatically take the injection because it is marked on your calendar. Call the prescriber and let the medical situationnot the calendar appmake the decision.
Pain relievers
No direct Skyrizi interaction is established with acetaminophen, ibuprofen, naproxen, or aspirin. However, these medications have independent risks.
Acetaminophen may require extra caution in people with liver disease or those taking other liver-affecting medications. Nonsteroidal anti-inflammatory drugs such as ibuprofen and naproxen can irritate the stomach, affect the kidneys, increase bleeding risk, and aggravate digestive symptoms in some people with inflammatory bowel disease.
Ask your doctor or pharmacist which pain reliever fits your diagnosis and medical history instead of assuming that every over-the-counter product is harmless because it arrived without a prescription.
Blood thinners, acid reducers, heart medications, and birth control
Clinical testing did not find a meaningful effect of risankizumab on exposure to warfarin, omeprazole, or metoprolol. Nevertheless, drugs such as warfarin still require their usual monitoring because their risks exist independently of Skyrizi.
No interaction with hormonal birth control is listed in the FDA prescribing information. This does not answer questions about pregnancy safety, however. Tell your healthcare provider if you are pregnant, planning pregnancy, breastfeeding, or become pregnant during treatment.
Skyrizi and vaccines
Vaccines are among the most important Skyrizi interactions to discuss. The prescribing information advises patients to avoid live vaccines during treatment and immediately before or after treatment. Because Skyrizi changes immune activity, a live vaccine could present an infection risk.
Examples of live vaccines may include:
- Measles, mumps, and rubella vaccine
- Chickenpox vaccine
- Nasal-spray influenza vaccine
- Oral typhoid vaccine
- Yellow fever vaccine
Not every vaccine is live. Injectable influenza vaccines, current COVID-19 vaccines used in the United States, and the Shingrix shingles vaccine are non-live. Non-live vaccines are generally considered safer for people receiving immune-modifying therapy, although the immune response may not be as strong in some patients.
Complete age-appropriate vaccinations before starting Skyrizi when possible. If you need a vaccine while receiving treatment, tell the pharmacist or vaccination provider that you use risankizumab. Your prescriber can help coordinate timing.
Can you drink alcohol while taking Skyrizi?
Alcohol is not listed as a direct Skyrizi interaction in the U.S. prescribing information. There is no evidence that an alcoholic beverage immediately changes how risankizumab is absorbed or broken down.
That answer comes with several important footnotes. Alcohol can affect the liver, immune function, gastrointestinal tract, sleep, hydration, and medication adherence. It may also worsen psoriasis or digestive symptoms in some people. Anyone below the legal drinking age should not drink alcohol.
Avoiding alcohol is particularly important when you:
- Have liver disease, cirrhosis, or abnormal liver tests
- Take methotrexate, acetaminophen, or another medication that can affect the liver
- Are undergoing Skyrizi induction treatment for Crohn’s disease or ulcerative colitis
- Notice that alcohol triggers skin, joint, or gastrointestinal symptoms
- Are currently ill, dehydrated, or being treated for an infection
Drug-induced liver injury was reported during intravenous Skyrizi induction in a patient with Crohn’s disease. Because of this risk, liver enzymes and bilirubin should be evaluated before and during induction treatment for Crohn’s disease or ulcerative colitis, with continued monitoring based on clinical care.
Seek prompt medical advice for yellowing of the eyes or skin, dark urine, unusual fatigue, loss of appetite, persistent nausea, upper abdominal pain, or an unexplained rash. These symptoms do not automatically mean Skyrizi has injured the liver, but they deserve evaluation rather than an internet detective badge.
Skyrizi interactions with food, grapefruit, and supplements
Food and grapefruit
The prescribing information does not identify a Skyrizi interaction with food or grapefruit. Since the medication is administered by injection or infusion rather than swallowed, meals do not control its absorption.
Grapefruit may still interact with another medication in your regimen, such as certain cholesterol, blood pressure, or immune-suppressing drugs. Review the entire medication list before declaring grapefruit innocent.
Vitamins and herbal supplements
Specific studies of Skyrizi with most vitamins, herbal products, and dietary supplements are limited. “Natural” is a marketing category, not a guarantee of interaction-free behavior.
Some supplements can affect the liver, bleeding risk, immune function, or the metabolism of companion medications. Give your pharmacist a complete list that includes multivitamins, protein or wellness powders, CBD products, herbal teas, traditional remedies, and occasional supplements. Include the dose and frequency whenever possible.
Questions to ask before starting Skyrizi
- Should I receive any vaccines before my first dose?
- Do any of my current medications suppress the immune system?
- Should I continue methotrexate, steroids, or other IBD medications?
- What should I do if I develop an infection before injection day?
- Do I need tuberculosis screening or liver blood tests?
- Could alcohol or supplements create problems with my other medications?
- Which symptoms require an urgent call or emergency care?
When to seek medical help
Get emergency help for trouble breathing, throat tightness, facial or tongue swelling, fainting, chest tightness, widespread hives, or other signs of a serious allergic reaction.
Contact your healthcare provider promptly for symptoms of infection, possible tuberculosis, or liver problems. Also call before your next dose if you are taking antibiotics for a significant infection, have scheduled surgery, or recently received a vaccine that may have been live.
Conclusion
Skyrizi has relatively few classic drug interactions because it is a monoclonal antibody and is not handled by the body like many oral medications. Even so, the immune system does not operate in separate little compartments. Other biologics, JAK inhibitors, steroids, methotrexate, infections, vaccines, alcohol, and liver-affecting drugs can change the overall safety picture.
Keep an updated medication list, include supplements and occasional over-the-counter products, and share it with every prescriber and pharmacist involved in your care. When a new medication, vaccine, or infection appears, check before taking the next dose. That five-minute conversation is much easier than untangling a preventable complication later.
Real-world experiences and practical lessons
The following examples are illustrative composites based on common medication-management situations. They are not individual patient testimonials and should not be treated as personalized medical advice.
The travel vaccine surprise
A person using Skyrizi schedules an international trip and visits a travel clinic. Most of the appointment feels routine until the clinician mentions an oral typhoid vaccine and a yellow fever vaccine. Both may be live vaccines, which changes the conversation immediately.
The practical lesson is to begin travel planning early. Waiting until the week before departure can leave too little time to coordinate vaccination, consider non-live alternatives, adjust the itinerary, or obtain medical documentation. The traveler should tell the clinic about Skyrizi before any vaccine is prepared, not while the needle is already waving hello.
The antibiotic-and-injection-day dilemma
Another patient develops a painful skin infection several days before a scheduled Skyrizi injection. An urgent care clinician prescribes an antibiotic but does not know the patient’s biologic schedule. The patient searches for an antibiotic interaction and finds none, which appears reassuring.
The missing detail is that the active infection matters more than a direct chemical interaction. After contacting the Skyrizi prescriber, the patient receives individualized instructions about when treatment can resume. The useful habit here is to contact the prescribing team whenever a significant infection overlaps with injection day. Do not make the decision solely from an interaction checker.
The methotrexate misunderstanding
A person with psoriatic arthritis takes both methotrexate and Skyrizi. They read that Skyrizi has no known direct interaction with alcohol and assume the entire treatment plan carries the same answer. Their pharmacist points out that methotrexatenot Skyriziis the medication creating the stronger liver-related concern.
This illustrates why interaction questions should include every drug, not just the newest or most expensive one. A combination may be acceptable while one component still requires laboratory monitoring, dietary restrictions, or alcohol avoidance.
The “just a supplement” problem
A patient reports taking no additional medications but later mentions an herbal sleep product, a concentrated turmeric supplement, and several workout powders. None felt important enough to place on the medication list.
The pharmacist reviews the ingredients and discovers that some could affect bleeding, the liver, or other prescriptions. The lesson is simple: if a product enters your body for a health purpose, put it on the list. The category includes gummies, teas, powders, drops, oils, and products advertised with suspiciously enthusiastic leaves on the label.
The vaccine-name mix-up
A patient hears that shingles vaccines can be risky with immune-suppressing drugs and assumes every shingles vaccine is live. In the United States, Shingrix is a non-live vaccine, while an older shingles vaccine was live. The patient’s care team confirms the appropriate product and timing.
Remembering brand names is less useful than asking one direct question: “Is this a live vaccine?” That question helps the vaccination provider verify the formulation rather than relying on memory or a decade-old article.
The medication-list habit that prevents confusion
Many interaction problems are not dramatic. They begin with incomplete records: one specialist does not know about a steroid prescribed elsewhere, an urgent care clinic misses the biologic, or a patient forgets the name of a weekly medication.
A practical solution is to keep one updated list on your phone. Include medication names, doses, schedules, supplements, allergies, recent vaccines, and the prescriber responsible for each treatment. Update it after every appointment. Skyrizi interactions are usually manageable, but good communication is the quiet superhero doing most of the work.